In order to account for the multi-phasic dynamics of photopigment regeneration in human rods, we developed a new model of the retinoid cycle. We first examined the relative roles of the classical and channeling mechanisms of metarhodopsin decay in establishing these dynamics. We showed that neither of these mechanisms alone, nor a linear combination of the two, can adequately account for the dynamics of rhodopsin regeneration at all bleach levels. Our new model adds novel inhibitory interactions in the cycle of regeneration of rhodopsin that are consistent with the 3D structure of rhodopsin. Our analyses show that the dynamics of human rod photopigment regeneration can be accounted for by end-product regulation of the channeling mechanism where all-trans retinal (tral) inhibits the binding of 11-cis retinal to the opsin.tral complex.
Introduction
Light perception in vertebrates' photoreceptors is mediated by G-protein-coupled receptors called opsins. Rhodopsin is the light-sensing molecule of rod photoreceptors. It is composed of the opsin protein and a vitamin A-1 derived chromophore, 11-cis retinal (cral). The chromophore is attached to the active site of rhodopsin via a Schiff base bond with Lys 296 . In the dark, a salt bridge between the protonated Schiff base and Glu 113 stabilizes the ground state conformation of rhodopsin. When a photon interacts with cral it causes the chromophore to isomerize to its all-trans configuration (tral). This isomerization induces a number of intra-molecular steric interactions that lead to disruption of the salt bridge and conversion of rhodopsin into its active form, metarhodopsin II (MII) (Bifone, de Groot, & Buda, 1997; Meng & Bourne, 2001; Ritter, Zimmermann, Heck, Hofmann, & Bartl, 2004; Yamada, Yamato, Kakitani, & Yamamoto, 2004) . Subsequently MII interacts with transducin, a heterotrimeric G-protein that in turn initiates the reactions of the phototransduction cascade (for reviews see Burns & Arshavsky, 2005; Burns & Lamb, 2003; Burns & Taylor, 2001) .
Rhodopsin is rapidly deactivated through the action of rhodopsin kinase which phosphorylates a number of serines and threonines on the C-terminal of rhodopsin (Arshavsky, 2002; Kennedy, Lee, Niemi, Craven, & Garwin, 2001; Ohguro, Van Hooser, & Milam, 1995; Zhang, Sports, Osawa, & Weiss, 1997) . Final quench of MII activity occurs when its transduction interaction site is capped by the water soluble protein, arrestin. Following inactivation, in order to regain photosensitivity, rhodopsin requires the isomerization of tral back to cral and its re-insertion and attachment to rhodopsin's active site. In vertebrate photoreceptors this process occurs through a collection of chemical reactions known as the retinoid cycle or visual cycle (reviewed in Lamb & Pugh, 2004; McBee, Palczewski, Baehr, & Pepperberg, 2001; Rando, 2001; Saari, 2000) . Reactions of the retinoid cycle take place within the rod outer segment (ROS) and retinal pigment epithelium (RPE) and are depicted in Fig. 1 .
The first step of the retinoid cycle involves decay of MII which begins with hydrolysis of the Schiff base bond between tral and Lys 296 . Concurrent with this process a storage form of rhodopsin, metarhodopsin III (MIII) is generated (Heck, Schädel, Maretzki, Bartl, & Ritter, 2003) . Classical studies (Matthews, Hubbard, Brown, & Wald, 1963; Wald, 1968) suggested that following the hydrolysis of the Schiff base, tral separates from the opsin apo-protein. According to this mechanism, subsequent to its release into the ROS cytoplasm, most of tral is reduced by NADPH-dependent trans-retinol dehydrogenase (tRDH) to all-trans retinol (trol) (see Fig. 1a ). The remaining tral diffuses in the lipid phase where it forms a condensation product with phosphatidylethanolamine. Eventually the condensation product is flipped across the membrane to the ROS cytoplasm by an ATP-binding cassette transporter (ABCR) (Weng, Mata, Azarian, Tzekov, & Birch, 1999) where it is hydrolyzed. tral is then reduced by tRDH in the cytoplasm.
However, recent studies by Schädel and co-workers (Heck, Schädel, Maretzki, & Hofmann, 2003; Schädel et al., 2003) suggest that a ''retinal channeling'' mechanism could be the primary pathway of metarhodopsin decay and that the ''classical pathway'' plays a negligible role in the dynamics of rhodopsin regeneration. According to the channeling hypothesis, following the hydrolysis of the Schiff base, tral diffuses out of the active site but is prevented from leaving the protein. Instead, tral is transported to another retinoid binding site labeled, the ''exit site''. The exit site is accessible only to the tral that is released from the rhodopsin active site (i.e. free tral in the lipid phase cannot bind to this site) . It is at this site that reduction of tral by tRDH occurs. The resultant trol remains attached to this site until a third retinoid binding site labeled the ''entrance site'' is occupied by a cral molecule (see Figs. 1b and 2a) . In a process reminiscent of the classical mechanism, it has been proposed that in conditions where large bleaches of rhodopsin exceed the capacity of tRDH to reduce tral, tral dissociates from the exit site and diffuses into the lipid phase where it eventually is transported back to the cytoplasm via the action of ABCR.
Regardless of the mechanism of metarhodopsin decay, the resultant trol is transported across the inter-photoreceptor matrix and into the RPE where, following a series of reactions, it is re-isomerized back to cral. Upon trol's entrance into the RPE, fatty acids are used to esterify trol in a reaction catalyzed by lecithin:retinol acyltransferase (Berman, Horowitz, Segal, Fisher, & Feeney-Burns, 1980; Rando, 1991; Ruiz, Winston, Lim, Gilbert, & Rando, 1999; Saari & Bredberg, 1988; Saari & Bredberg, 1989; Shi, Furuyoshi, Hubacek, & Rando, 1993; . The resulting all-trans-retinyl ester (tRE) is then chaperoned by the protein RPE65 to a retinyl ester isomerohydrolase (Gollapalli, Maiti, & Rando, 2003; Gollapalli & Rando, 2003a , 2003b Mata, Moghrabi, Lee, Bui, & Radu, 2004; Moiseyev, Crouch, Goletz, Oatis, & Redmond, 2003) which catalyzes its conversion to 11-cis retinol (crol). It should be noted that recent reports have nominated RPE65 as the previously unidentified isomerohydrolase enzyme (Moiseyev, Chen, Takahashi, & Wu, 2005; Moiseyev, Takahashi, Chen, Gentleman, & Redmond, 2006; Redmond, Poliakov, Yu, Tsai, & Lu, 2005) . Finally, the cycle is completed when the crol is oxidized by 11-cis retinol dehydrogenase to cral and is transported back to the ROS.
Recently, Mahroo, Lamb and Pugh (MLP) , (Lamb & Pugh, 2004; Mahroo & Lamb, 2004) have developed a rate-limited model of pigment regeneration in vertebrate photoreceptors that accounts for various aspects of dark adaptation and for the effects of some genetic mutations that lead to defective retinoid delivery and visual dysfunction (Lamb & Pugh, 2004; Mahroo & Lamb, 2004; Wenzel, Oberhauser, Pugh, Lamb, & Grimm, 2005) . However, despite its predictive utility, the MLP model is unable to account for the observation that rhodopsin regeneration has an early fast recovery phase, and a later slow phase (Jäger, Palczewski, & Hofmann, 1996; Kolesnikov, Shukolyukov, Cornwall, & Govardovskii, 2006) . We believe that the cause of this shortcoming is that in MLP, the dynamics of metarhodopsin decay are ignored and only the process of recombination of cral with opsin and/or the opsin-trol complex (Ops AE trol) is explicitly modeled.
Additionally, a possible origin of the observed rhodopsin regeneration behavior is the interplay between the two known pathways of metarhodopsin regeneration, i.e. the classical mechanism (CLM) and the channeling mechanism (CHM). In order to examine the relative roles of CHM and CLM on the overall dynamics of photopigment regeneration in human rods, we developed a model that incorporates both pathways into an MLP-like model of cral transport and insertion. The difference between this model and MLP is that, where the latter ignores the time course of metarhodopsin decay and Ops AE tral reduction by tRDH, we explicitly accounted for the kinetics of these steps.
The results of our simulations show: (a) neither CLM nor CHM can account for the observed rhodopsin regeneration dynamics; (b) simple linear combinations of the two pathways do not account for the fast-slow, bi-phasic nature of rhodopsin regeneration. Based on these results we propose a possible biochemical scheme that can account for photopigment regeneration dynamics. Our new model assumes that all metarhodopsin decays via CHM but with tral acting as an end-product inhibitor of the fast binding . The displayed image is that of bovine rhodopsin (pdb 1HZX (Teller et al., 2001) ). (b) A closeup look at the location of the retinoid binding sites on bovine metarhodopsin (PDB 1LN6, (Choi et al., 2002) ). The yellow colored amino acids indicate the binding site of cral at the entrance site, while red amino acids represent the tral binding site at the entrance site. The blue colored amino acids denote the retinoid exit site. The location of these three sites are in close enough proximity to each other that it is possible that binding of two retinoids could sterically hinder the binding of a third. Images produced using Deepview/Swiss-pdbViewer.
reaction of cral to Ops AE tral. The proposed mechanism involves early post-flash binding of cral to Ops AE tral, a process which due to tral inhibition eventually is replaced by cral binding to Ops-trol. This scheme can accurately account for the data, including the two phases of photopigment regeneration.
Models and methodology
Our models builds upon the MLP model of the retinoid cycle. The major differences from the MLP model are:
(a) We include the interconversion of MII and MIII, and the decay of these species via the classical pathway and/or the channeling mechanism. (b) We specifically account for the activity of the enzyme all-trans retinol dehydrogenase.
Models were developed using Karyote cell simulator (Ortoleva, Berry, Brun, Fan, & Fontus, 2003; Weitzke & Ortoleva, 2003) . The reactions implemented are presented in Table 1 . Table 2 , lists the parameters used. The models simulate the interactions between two compartments, one representing 20 rod outer segments and other, a single RPE cell (Lamb & Pugh, 2004) .
Model assumptions
1. All the reactions are considered to be finite rate reactions. Thus, the conservation of mass equation for species i in compartment a is written as:
where c a i is the concentration of species i in compartment a, n c is the total number of compartments, F b!a i is the flux of species i from compartment b into compartment a, and n a i is the net rate of reactions involving species i. 2. We assume that conversion of rhodopsin to MII is instantaneous and that all of our metarhodopsin decay processes are irreversible. The parameters we use for these processes are those reported by Lamb and Pugh (2004) (see Table 2 ). 
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3. Although the activity of ATP-binding cassette transporters (ABCR) is of utmost importance to the overall health of retina (see Cideciyan, Aleman, Swider, Schwartz, & Steinberg, 2004; Mata, Tzekov, Liu, Weng, & Birch, 2001; Suarez, Biswas, & Biswas, 2002; Sun, Smallwood, & Nathans, 2000; Weng et al., 1999) , it has been proposed that the activity of ABCR does not significantly affect the dynamics of recovery from a single bleaching exposure (Lamb & Pugh, 2004) . Thus, we do not account for the processes involved in the transport of tral from the inside of disc membranes to their cytoplasmic surface. 4. As in the MLP model, we assume that the concentration of cral in the RPE is constant. This is equivalent to assuming that there is rapid replenishment of cral in the RPE from retinoid stores in RPE and choroid (see Bridges, Alvarez, & Fong, 1982; Imanishi, Batten, Piston, Baehr, & Palczewski, 2004) . 5. We assume that, under dark adapted conditions cral equilibrates between the RPE and ROS, and there is no net transport across the inter-photoreceptor matrix.
The dark concentration of cral was derived from measurements by Maeda et al. (Maeda, Maeda, Imanishi, Kuksa, & Alekseev, 2005) . We subtracted their measured value of rhodopsin concentration (468 pmol/eye) from their measured value of total cral per mouse eye (529 pmol/eye) to come up with a value of 60.9 pmol of free cral per mouse eye. Dividing this amount equally between RPE cells and rod outer segments yields an estimate of 30.45 pmol of cral in mouse ROS. Assuming that a rhodopsin concentration of 468 pmol/eye corresponds to 2.6 mM, then 30.45 pmol of cral in the ROS corresponds to 0.169 mM.
Model development
The flux of cral from RPE to ROS is governed by the equation:
where A is the area of membrane between RPE and twenty rod outer segments, V ROS is the volume of twenty rod outer segments, and h RPE!ROS cral is the parameter quantifying how fast cral can traverse the membrane.
In the MLP model, the rate of bimolecular binding reaction (f(t)) between cral and opsin is expressed as:
where k R is the bimolecular rate constant for binding of cral to opsin and/or Ops AE trol, O(t) represents the transient Jäger et al. (1996) . a Based on observations in prRDHÀ/À mice that the rate of production of trol in these animals was a quarter of that for wild type (Maeda et al., 2005) , we multiplied the turnover number reported by Belyaeva et al. by four and used this value in our simulations. b We optimized the h
RPE!ROS cral
and k R parameters to fit to the experimental data using the range of K m value from Lamb and Pugh (2004) . c k tral was determined by using the optimized k R value and the experimental observation (Jäger et al., 1996) that for opsin k R = 2.5 · k tral . * Unless otherwise listed, the values listed under pure CLM were used for all four models. concentration of the species that cral binds to (i.e. Opsin and/or Ops AE trol) and R is the ''resistance'' to import of cral from RPE to ROS.
If, like MLP, we assume that fðtÞ ¼ F
, then using Eq. (3) we can write MLP's R as:
MLP's semi-saturation constant (K m ) for Ops-trol and/or opsin's rate-limited removal can be written as:
Since we assume that a cell's dimensions do not change with time, we can write A/V ROS = X, a constant, and thus:
Based on Eq. (6), we could derive estimates for the values of the bimolecular rate constant k R and h
by fitting the models to experimental data (e.g. reflection densitometry measurements) (Alpern, 1971; Rushton & Powell, 1972) . The value of K m was constrained to 0.52 mM (i.e. 0.2 times the total rhodopsin concentration in ROS, Lamb & Pugh, 2004) .
Results
Classical mechanism as the sole pathway of metarhodopsin decay does not account for the data
In order to simulate pigment regeneration via a purely CLM pathway of metarhodopsin decay, the rate constants for the CHM reactions were set to zero (see Table 1 ). Using experimental data (Alpern, 1971; Rushton & Powell, 1972) , we optimized the k R = 87 M À1 s À1 and h RPE!ROS cral = 2.27 · 10 À7 dm s À1 values. Results of these simulations are shown in Fig. 3 . Fig. 3 compares the predictions of the pure CLM model with reflection densitometry measurements of rhodopsin regeneration in the human eye (Alpern, 1971; Rushton & Powell, 1972) . The CLM, model even with optimized parameters provides a poor fit to the experimental data. Inclusion of the metarhodopsin decay adds a delay to the time course of recovery (Lamb & Pugh, 2004 calculated this delay to be approximately 0.8 min for a hundred percent bleach). The predicted delay varies with bleach levels and, in fact, increases at lower bleach levels.
The problem caused by this delay cannot be ameliorated by adjusting the kinetic parameters so as to match the data more closely for low bleach levels. Indeed, if we optimize h RPE!ROS cral and k R (while maintaining K m constant across Fig. 3 . Rhodopsin regeneration dynamics cannot be accounted for with a model in which CLM is the sole pathway of metarhodopsin decay. The model predictions (solid curves) are compared with reflection densitometry measurements of rhodopsin regeneration in the living human eye (bowties: Alpern, 1971 ; all other data: Rushton and Powell, 1972) . Results for three bleach levels are shown: 51.5% (triangles), 67% (squares), and 100% (bowties and diamonds). Because our implementation of the CLM model includes explicit equations for metarhodopsin decay, as well as for reduction of tral to trol by tRDH, the predicted regeneration dynamics have a sigmoidal shape, and thus do not increase as quickly as the regeneration data. The extent of this delay in rhodopsin regeneration is more pronounced for smaller bleaches. bleach levels) so as to fit the data for small bleaches, then the model predictions will fit the data for high bleach levels even more poorly than shown in Fig. 3. 
Channeling mechanism as the sole pathway of metarhodopsin decay does not accurately account for the data
In order to test how well a pure CHM Schädel et al., 2003) model would account for the data, we implemented the generation of Ops AE tral from metarhodopsin as well as the reduction of Ops AE tral by tRDH to form Ops AE trol. For these simulations, the kinetic parameters for all the non-channeling reactions were set to zero. Thus for these simulations, there is no free Ops or tral present and all of the decaying metarhodopsin converts to Ops AE tral.
The results of our simulations with a pure CHM model are shown in Fig. 4 . The values for k R and h RPE!ROS cral that yield the best fit for a pure CHM model are over 5 times larger than they are for a pure CLM model (k R = 485.5 M À1 s À1 and h
. This difference is due to the fact that, in the pure CHM model, rhodopsin regeneration dynamics are dependent on the rate-limited reduction of tral to trol by the enzyme tRDH. When the measured experimental values are used for the generation of Ops AE trol by tRDH (Palczewski, Jäger, Buczylko, Crouch, & Bredberg, 1994) , the inclusion of this reaction exaggerates the sigmoidal nature of the photopigment regeneration dynamics as compared with the CLM simulations (see Fig. 3 ). We can improve the result for small bleaches by increasing k R and cral flux, but this leads to a severe mismatch with the data from more intense bleaches (recovery is far too fast, results not shown).
These simulations show that a model in which metarhodopsin decay proceeds entirely via the proposed CHM Schädel et al., 2003) does not provide an accurate account of the dynamics of rhodopsin regeneration, particularly for the first few minutes following the flash.
A special case of the CHM model merits consideration. For scenarios where large bleaches of rhodopsin may exceed the capacity of tRDH, regeneration via CHM could proceed through the binding of cral to Ops AE tral, and simultaneous release of a tral from the exit site ). The freed tral would then diffuse into the lipid phase where it would undergo some changes (see Discussion) and eventually is transported back to the cytoplasm through the action of ABCR. In order to evaluate the effect of this alternate hypothesis on the dynamics of rhodopsin regeneration we added to the CHM model the proposed interaction between Ops AE tral and cral (see Table 1 ). For these simulations we used the same k R for binding of cral to Ops AE tral and Ops AE trol.
The results of these simulations are shown in Fig. 5 . They are in closer agreement with experimental data than when cral was restricted to bind only to Ops AE trol. The results, in fact, are similar to those shown in Fig. 3 (pure CLM rhodopsin regeneration). Given the fact that the rate Fig. 4 . Rhodopsin regeneration dynamics cannot be accounted for with a model in which CHM, as delineated in Schädel et al. (2003) , is the sole pathway of metarhodopsin decay. The predicted regeneration dynamics (solid curves) have an even more pronounced sigmoidal shape than for the pure CLM model (Fig. 3) . The resulting delay following a bleach fails to reproduce the empirical regeneration dynamics, and, as for the CLM simulation, becomes more pronounced following less intense bleaches. The coding for the model curves and data are the same as in Fig. 3. of formation of Ops and Ops AE tral are equal in the model, similarity is not surprising.
The predicted amount of free tral that is produced for these simulations is very high. Our results indicate that over 90% of regenerated rhodopsin is produced via combination of cral with Ops AE tral. Since one of the proposed advantages of CHM is that it protects the ROS from being flooded by toxic tral, this scheme, as proposed, seems to invalidate one of the main arguments for the physiological necessity of CHM. Based on this result we can conclude that either: (a) cral does not interact with Ops AE tral, or (b) the rate of combination of cral to Ops AE tral is slower than that of cral with Ops AE trol, or (c) interaction of cral with Ops AE tral is somehow regulated by an end-product. Since there is no physiological basis for the first two hypotheses, we propose that for a purely CHM process, an end-product regulatory mechanism has to govern the dynamics of cral binding to different opsin-retinoid complexes.
Combined metarhodopsin decay via both CLM and CHM does not account for the measured data
Next we simulated conditions where both classical and channeling mechanisms control metarhodopsin decay. Fig. 6 shows the results of two such cases; the combination that gave us the best overall fit to experimental data (57% CLM:43% CHM (a)), and one where the results for low bleaches were relatively improved (80% CLM:20% CHM (b)). The k R value for both sets of simulations were 206.6 M À1 s À1 and h
RPE!ROS cral
¼ 5:4 Â 10 À7 dm s À1 . No combination of CHM and CLM provides an adequate account of the measured early post flash dynamics of rhodopsin regeneration. When CHM dominates, a sigmoidal form is imposed on the model predictions, and it fails to capture any of the experimental data (especially those for lower bleaches). When CLM dominates (thin gray lines) the model is better able to capture the regeneration dynamics for the two smaller bleaches. However, the high bleach data cannot be satisfactorily reproduced.
A new proposed scheme to account for the data: tral regulated decay of metarhodopsin
Our analyses indicate that neither the classical mechanism (Fig. 3) , nor the channeling mechanism (Figs. 4 and 5), nor linear combinations of the two (Fig. 6) can explain the complex dynamics of rhodopsin regeneration. These results, plus other evidence that rhodopsin regeneration cannot be described by a single exponential function (Kolesnikov et al., 2006) and that it has an early fast and later slow phase (Jäger et al., 1996) , led us to examine the notion that regulatory product inhibition might explain the multiphasic dynamics of rhodopsin regeneration. If bleaches exceed the capacity of tRDH, it has been proposed that regeneration could proceed via CHM through the binding of cral to Ops AE tral, and simultaneous release of a tral from the exit site . Thus, for these simulations we allowed cral to bind to Ops AE tral as well as Ops AE trol using k R = 87 M À1 s À1 for both, and h
RPE!ROS cral
¼ 2:27 Â 10 À7 dm s À1 . The results are in closer agreement with experimental data than when cral was restricted to bind only to Ops AE trol, as in Fig. 4 . The less pronounced sigmoidal dynamics are similar to the predictions from the CLM model. Symbology as in Figs. 3 and 4. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.) Fig. 6 . Predicted dynamics using linear combinations of CHM-and CLM-mediated rhodopsin regeneration are also inadequate to account for the data at all bleach levels. The simulation using the optimal combination of CLM and CHM (57% of the metarhodopsin decay proceeded via CLM, and 43% via CHM), shown as thick solid curves, did not provide an adequate account of the data for all three bleach levels. None of the combinations of CLM and CHM examined were able to account for the multi-phasic regeneration dynamics for all bleach levels. The thin gray curves show the results of a second simulation in which CLM was more dominant in metarhodopsin decay; 80% via CLM and 20% via CHM. This result illustrates our finding that, when both mechanisms are present, greater dominance by CLM provides a better account of the fast, early fast phase of regeneration for all three bleaches. For both simulations k
Symbology is the same as in Figs. 3-5. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this paper.) Fig. 7 . Our new regulated CHM model can account for the empirical rhodopsin regeneration, including the multi-phasic dynamics, for all three bleach levels using one set of parameters. For these simulations, we implemented a set of regulatory reactions for CHM (see Table 1 ) whereby binding of tral to the Ops-tral complex would inhibit its binding to cral. The model correctly predicts that the early stages of the regeneration process (the first $180 s after a bleach) are dominated by the fast binding of cral to Ops-tral complex. After this fast, early phase, most of the regeneration process then proceeds via binding of cral to Ops-trol, similar to the unregulated version of the CHM model. Symbology as in Figs. 3-6 .
End-product (tral) inhibition of cral binding to Ops Á tral
As mentioned in Section 3.2, have proposed that, following large bleaches of rhodopsin that might exceed the capacity of tRDH to reduce Ops-tral to Ops AE trol, rhodopsin regeneration via CHM could proceed through the binding of cral to Ops AE tral. The process leads to simultaneous release of a tral from the exit site which then would diffuse into the lipid phase and eventually be transported back to the cytoplasm by the action of ABCR transporter.
Upon examining the location of the proposed retinoid binding sites on rhodopsin , we note that the three retinoid binding sites (tral at the exit site, tral at the entrance site, and cral at the entrance site, see Fig. 2b ), are clustered in close proximity to one another. Some of the crucial amino acids that form the different binding sites are closely bunched together. Given the proximity of the binding sites, it is possible that binding of retinoids to two of these sites could sterically hinder the binding of retinoids to the third site. For example, if a trol is bound to the exit site and a cral binds to the entrance site, then the binding of tral to the entrance site could be hindered. Based on this assumption, we propose that binding of a tral molecule to the entrance site of an Ops AE tral complex could hinder the binding of cral to the entrance site of the same protein. To test whether this type of endproduct regulation would allow a purely CHM model to accurately capture the salient features of rhodopsin regeneration dynamics, we implemented such a regulatory scheme (see reactions 13-20 in Table 1 ). The results of these simulations are shown in Fig. 7 .
As can be seen, the results of these simulations closely match the experimental data for all three bleach levels. Furthermore, examination of the amount of tral produced by the process shows that, although majority of cral interacts with Ops AE tral molecules, free tral's concentration in the cytoplasm of ROS does not exceed 19% of the total amount of bleached rhodopsin.
Discussion
We have developed a new biochemical model of the retinoid cycle in vertebrate rods. An earlier model introduced by Mahroo, Lamb, and Pugh (MLP) (Lamb & Pugh, 2004; Mahroo & Lamb, 2004) was able to account for many of the quantitative details of rhodopsin regeneration across different bleach levels and experimental approaches (reflection densitometry, ERG, psychophysics). However, we sought to explain observed complexities in the rhodopsin regeneration kinetics that were beyond the scope of the MLP model, namely the multi-phasic nature of rhodopsin regeneration that is clearly evident in the reflection densitometry data (see Figs. 3-7) . No model to date, including the MLP, predicts the fast early phase and later slow phase evident in these data and noted by others (Jäger et al., 1996; Kolesnikov et al., 2006) .
In order to address these problems, we first expanded on the MLP model by including the kinetics of metarhodopsin decay and reduction of tral to trol. In addition, unlike MLP, we included features of both the classical and channeling mechanisms of metarhodopsin decay.
We found that addition of these explicit kinetic details exacerbated the difficulty in accounting fully for the data (see Figs. 3 and 4) . These processes impose an unavoidable sigmoidal rise to pigment regeneration dynamics that is antithetical to capturing the early fast phase of regeneration and the transition into the slow phase. We showed that the two proposed mechanisms for the decay of metarhodopsin and regeneration of rhodopsin, the classical and channeling mechanisms, cannot account fully for the data, either alone (Figs. 3-5 ) or in combination (Fig. 6) .
Experimental observations indicate that pathways analogous to both CLM and CHM contribute to decay of metarhodopsin. The fluorescence spectroscopic data and the results of the molecular modeling simulations presented by Schädel et al., 2003 provide strong support for their proposed channeling mechanism. CHM agrees with Lamb and Pugh's (2004) proposal that the rate limiting step of the retinoid cycle is the delivery of cral from RPE to opsin/Ops AE trol. Additionally, the CHM can explain the similarity between the rates of rhodopsin regeneration and release of trans-retinoids from the rhodopsin's active site. This is due to the fact that according to the CHM scheme, it is the binding of cral to the entrance site of rhodopsin that determines the rate of trol/tral release into the ROS cytoplasm and not vice versa, as previously had been proposed (Saari, Garwin, & Van Hooser, 1998) .
The CHM also makes physiological sense, since it has the fortuitous effect of protecting the system from being flooded by free tral which could seriously hinder dark adaptation and lead to a number of retinal diseases. These stated advantages are serious factors that argue against a pure CLM mechanism of metarhodopsin decay. However, it is well known that, as with CLM, some portion of the bleached rhodopsin quickly release their isomerized chromophores into the ROS cytoplasm which eventually reach the lumenal region of the rod discs (Lamb & Pugh, 2004; Weng et al., 1999) . Upon release, a portion of this tral, through a spontaneous interaction with phophatidylethanolamine, forms the Schiff base N-retinylidene-PE (NrPE) (Anderson & Maude, 1970; Beharry, Zhong, & Molday, 2004) .
Under normal physiological conditions, NrPE is then removed from the inner region of the disc membrane through the action of the ABCR transporter Ahn, Wong, & Molday, 2000; Sun, Molday, & Nathans, 1999; Weng et al., 1999) . ABCR is a member of a family of proteins (ATP-binding cassette transporters) that can be found in all species. It uses the energy of ATP hydrolysis to translocate specific chemical species across cellular membranes. The activity of ABCR is crucial to the overall health of the retina and ABCR defects have been shown to lead to a number of retinopathies (Cideci-yan et al., 2004; Mata et al., 2001; Suarez et al., 2002; Sun et al., 2000) . The reason for this is that, in absence of ABCR's ''flippase'' activity, the NrPE in the rod discs interacts with a second molecule of tral to form a phosphatidyl-pyridinium biretinoid species known as A2-PE (Parish, Hashimoto, Nakanishi, Dillon, & Sparrow, 1998) which subsequently forms the compound N-retinylidene-N-retinylethanolamine (A2E). A2E is the major component of lipofuscin and does not undergo enzymatic degradation. Experiments have shown that alterations of ABCR activity can lead to accumulation of lipofuscin in RPE which eventually leads to a slow demise of the photoreceptors (Cideciyan et al., 2004; Mata et al., 2001; Mata, Weng, & Travis, 2000; Weng et al., 1999) .
Despite its clinical importance, it has been proposed that the functioning of ABCR transporter is not of great consequence to the overall processing of retinoids by the retinoid cycle (Lamb & Pugh, 2004) . Thus it can be reasoned that under normal conditions, some form of CHM is the primary pathway of metarhodopsin decay.
Neither CHM nor CLM can act as the sole pathway of metarhodopsin decay
Our theoretical analyses examined whether systems where metarhodopsin decay is purely governed by either CHM or CLM can adequately account for the observed multi-phasic dynamics of rhodopsin regeneration. Figs. 3 and 4 show that neither pathway alone was able to correctly predict the observed regeneration behavior.
4.1.1. Classical mechanism cannot be the only mechanism of metarhodopsin decay
Our CLM simulations confirm the MLP finding that including the time course of metarhodopsin decay in a model imposes a delay, in the calculated dynamics of rhodopsin regeneration in a fully bleached rod (Lamb & Pugh, 2004) . Lamb and Pugh argued that this delay is small (approximately 0.8 min) and thus chose not to include metarhodopsin decay in their model. However, our analyses reveal out that the delay associated with formation of opsin increases as the intensity of the bleach decreases, and thus, for smaller bleaches, this delay becomes significant. This greater deviation from the MLP predicted dynamics for smaller bleaches is due to the slower initial rates of metarhodopsin decay for such bleaches.
The initial rate of opsin formation is given by:
where c MII (0) is the concentration of metarhodopsin assumed to be instantaneously formed upon bleaching of rhodopsin; [R] tot is the pre-flash concentration of rhodopsin in the ROS; and B is the fraction of rhodopsin that was bleached. From this equation we can see that, the initial rate of metarhodopsin decay following 50% bleach would be half of the value for a fully bleached system.
In order to see if we could simulate the multi-phasic dynamics of rhodopsin regeneration by using a purely CLM model, we experimented with varying k R and h RPE!ROS cral from their optimal values (as shown in Fig. 3) , while maintaining MLP's K m constant at 0.52 mM (simulation results not shown). Our aim was to test if it is possible to overcome the delay associated with metarhodopsin decay by expediting the binding of cral to opsin. We were able to improve the predictions for smaller bleaches by increasing the above values; however this led to excessive increases in the rates of rhodopsin regeneration following large bleaches. Overall, our results, as well as the reported physiological advantages of CHM, argue that CLM cannot be the sole pathway of metarhodopsin decay.
Channeling mechanism cannot be the only mechanism of metarhodopsin decay
If we assume that CHM is the sole mechanism of metarhodopsin decay, and that cral can only bind to Ops AE trol, then the bimolecular rate constant needed to best fit the observed dynamics of rhodopsin regeneration must be more than 5 times larger than it is for a pure CLM mech- Figs. 3 and 4) . Even with a larger k R , the CHM model, as delineated in Schädel et al. (2003) , can never achieve an adequate fit to the data. This is because the slow kinetics of metarhodopsin decay and reduction of tral to trol impose an unavoidable pronounced sigmoidal dynamic to the overall rhodopsin regeneration plot (Fig. 4) . As we saw for a pure CLM model, parameter adjustment in order to match the fast phase of regeneration causes the model to miss the slow later phase of regeneration (and vice versa).
It might be argued that if cral can bind to Ops AE tral (as proposed by ), it would counteract the slowing of regeneration dynamics associated with the activity of tRDH. Indeed, we show in Fig. 5 that the regeneration dynamics predicted for such a scheme are closer to experimental measurements. If one assumes that the k R for binding of cral to Ops AE tral is the same as it is for Ops AE trol, then the process of regeneration will be dominated by binding of cral to Ops AE tral. However, this would negate one of the main advantages of the CHM, namely that the opsin protein chaperons the toxic tral and regulates the release of retinoids into the ROS cytoplasm. Furthermore, like CLM, this mechanism cannot accurately account for the bi-phasic nature of rhodopsin regeneration. It can only account for the dynamics either at high or low bleach levels but not both. Based on these results, it appears that CHM (as proposed by Schä-del et al., 2003) alone cannot account for all the salient features of the regeneration dynamics.
Unregulated combinations of CHM and CLM cannot accurately predict the observed behavior
We also evaluated whether a linear combination of CLM and CHM could account for the multi-phasic dynamics of rhodopsin regeneration. To this end, we simulated a variety of scenarios where the metarhodopsin decay kinetics were partitioned between CLM and CHM. Fig. 6 shows the result of the combination that gave us the best fit to experimental data (solid curves). As with simulations of CHM and CLM alone, the results of these simulations have a sigmoidal shape and thus do not account for the fast early phase of rhodopsin regeneration.
In our simulations, we could find no linear combination of CHM and CLM that could accurately describe the data. When CHM dominated, the delay associated with decay of metarhodopsin and reduction of Ops AE tral by tRDH could not be overcome. For scenarios where CLM dominated (see Fig. 6 , thin gray lines), the model could closely predict the dynamics of regeneration following small bleaches. We attribute this improvement to the faster combination of cral to opsin in comparison to Ops AE trol. Unfortunately, the faster dynamics associated with CLM dominance have an adverse effect on the predicted dynamics of regeneration for large bleaches.
Regulation of rhodopsin regeneration dynamics by tral can explain the observed bi-phasic behavior
Examination of Fig. 6 shows that when CLM dominates the dynamics of metarhodopsin decay, the model not only better captures the data for small bleaches, but also better captures the fast early phase of regeneration for all bleach levels. These observations led us to consider a scenario where, for the first few minutes following a flash, the contribution of fast processes like CLM to the process of regeneration dominates and is progressively inhibited thereafter.
4.3.1. End-product inhibition of cral binding to the Ops AE tral complex Because the CHM model has clear physiological advantages , we sought a plausible biochemical scheme that could capture the multi-phasic nature of regeneration using a regulated CHM mechanism. In support of such a mechanism is our demonstration (Fig. 5 ) that, if cral is permitted to bind to Ops-tral , the predicted regeneration dynamics will closely resemble the behavior of CLM.
We reasoned that, due to slow activity of tRDH, early in the regeneration process Ops AE trol would be at low concentration. Under such conditions, cral binds to Ops AE tral. We thus implemented a regulatory mechanism whereby the early portion of the rhodopsin regeneration dynamics is dominated by relatively fast binding of cral to Ops AE tral, and is later replaced by the slower binding of cral to Ops AE trol. In our scheme, tral is released following the binding of cral to Ops AE tral. This tral then binds to another Ops AE tral complex, inhibiting binding of cral to it. Thus as tral concentration builds (later in the regeneration process), the fast binding of cral to Ops AE tral is inhibited.
This new model is able to reproduce the retinal densitometry data, including the multi-phasic regeneration dynamics, for all three bleach levels with one set of parameters (Fig. 7) . It should be noted here that, to date two different steps of the retinoid cycle have been proposed as the rate-limiting step of the regeneration process. Lamb and Pugh (2004) have nominated the process of transport of cral from RPE to ROS and its binding to opsin as the rate-limiting step, while Palczewski (Palczewski et al., 1994) and Saari (Saari, 2000; Saari et al., 1998) have proposed that the activity of tRDH is the rate-limiting step in retinoid cycle (in mice). Our proposal serves as a bridge between these two hypotheses. In our regulated CHM model, the early fast portion of the regeneration results from fast binding of cral to Ops AE tral. Thus, the early rhodopsin regeneration is rate-limited by the rate of transport of cral from RPE to ROS (similar to Lamb and Pugh's proposal) . However, the slow later phase of regeneration is rate-limited by the action of the enzyme tRDH (consistent with Saari and Palczewski's suggestion).
Plausibility of the regulated channeling mechanism
It is known that following its release from opsin, tral has the ability to bind to rhodopsin and that the presence of these complexes adversely affect the recovery of the visual sensitivity following a flash (Buczylko, Saari, Crouch, & Palczewski, 1996; Jäger et al., 1996; Melia, Cowan, Angleson, & Wensel, 1997; Surya & Knox, 1998) . Schädel (Schä-del et al., 2003) proposed a location at the rhodopsin entrance site as the site for binding of exogenous tral (see Fig. 2b) .
A close examination of the proposed locations of retinoid binding sites on rhodopsin shows that the binding sites of tral at the entrance and exit sites, as well as the binding site of cral at the entrance site, are close to one another. In fact, some of the residues in the proposed binding sites are immediately adjacent to one another (e.g. One might argue against our regulatory scheme by noting that some experimental results indicate that, when tral binds and activates opsin, it does not inhibit the binding of cral to opsin (Däemen, 1978; Sachs, Maretzki, Meyer, & Hofmann, 2000) . However, these results are for binding of one tral and one cral to an apo-protein opsin (i.e. the exit site of opsin does not have a tral attached to it), and not the concurrent binding of three retinoids.
We also note that Jäger et al. (1996) have reported that they observed bi-phasic rhodopsin regeneration behavior for binding of cral to apo-opsin (i.e. in absence of tral). However, in their methods, Jäger et al. noted that to remove tral from the solution they used an aldehyde-selective gel chromatographic method. Such a method would preferentially remove the free tral from the solution; however, tral bound to the exit site of the opsin (as hypothesized by the channeling mechanism) would not be removed. Thus, we argue that Jäger et al.'s bi-phasic results are not incompatible with our model, since they likely represent combination of cral with Ops AE tral and Ops AE trol and not apo-opsin.
Finally, sachs et al. (Sachs et al., 2000) have presented in vitro data that appears to demonstrate that addition of tral to opsin initiates a positive allosteric effect, not an inhibitory effect, on the regeneration of rhodopsin. However, inclusion of such an allosteric activation in a model of rhodopsin regeneration would act so as to exaggerate a sigmoidal aspect to the photopigment regeneration. The Sachs et al. results thus seem to be qualitatively incompatible with the in vivo densitometry data which do not manifest any appreciable sigmoidal dynamic (Lamb & Pugh, 2004) .
Conclusions
We implemented detailed models of the retinoid cycle that expanded on the MLP model. We were able to show that neither of the two proposed mechanisms of rhodopsin regeneration-the channeling and classical mechanismscan account for the complex dynamics of regeneration for all the bleach levels tested. Nor can the data be accounted for by linear combinations of the two mechanisms.
We propose that the multi-phasic dynamics of rhodopsin regeneration in human rods can be explained through end-product (all-trans retinal) inhibition of 11-cis retinal binding to the Ops AE tral complex. Our new regulated CHM scheme has the physiological benefit that it prevents the cytoplasm of the ROS from being flooded by toxic tral since it predicts that almost equal amounts of tral will be chaperoned by the opsin protein at both the entrance site and exit site.
